Search

Author/Creator Del Vecchio, Michele

1. Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria. (September 2022)

Authors:
Larkin, James; Weber, Jeffrey; Del Vecchio, Michele; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, C. Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O.; Di Giacomo, Anna Marie; Middleton, Mark R.; De la Cruz-Merino, Luis; Arenberg...
Journal:
European journal of cancer
Issue:
Volume 173(2022)
Page Start:
285
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial. Issue 11 (November 2020)

Authors:
Ascierto, Paolo A; Del Vecchio, Michele; Mandalá, Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance; Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Márquez-Rodas, Iván; Butler, Marcus O; Maio, Michele; Middleton, Mark R; de la Cruz-Merino, Luis; Arenberger, Petr;...
Journal:
Lancet oncology
Issue:
Volume 21:Issue 11(2020)
Page Start:
1465
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915). Issue 3 (26th September 2022)

Authors:
Weber, Jeffrey S.; Schadendorf, Dirk; Del Vecchio, Michele; Larkin, James; Atkinson, Victoria; Schenker, Michael; Pigozzo, Jacopo; Gogas, Helen; Dalle, Stéphane; Meyer, Nicolas; Ascierto, Paolo A.; Sandhu, Shahneen; Eigentler, Thomas; Gutzmer, Ralf; Hassel, Jessica C.; Robert, Caroline; Carlino, ...
Journal:
Journal of clinical oncology
Issue:
Volume 41:Issue 3(2023)
Page Start:
517
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Anticancer innovative therapy congress: Highlights from the 10th anniversary edition. (June 2021)

Authors:
De Santis, Francesca; Fucà, Giovanni; Schadendorf, Dirk; Mantovani, Alberto; Magnani, Luca; Lisanti, Michael; Pettitt, Stephen; Bellone, Matteo; Del Sal, Giannino; Minucci, Saverio; Eggermont, Alexander; Bruzzi, Paolo; Bicciato, Silvio; Conte, Pierfranco; Noberini, Roberta; Hiscott, John; De Brau...
Journal:
Cytokine & growth factor reviews
Issue:
Volume 59(2021)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients. Issue 2 (15th February 2021)

Authors:
Huber, Veronica; Di Guardo, Lorenza; Lalli, Luca; Giardiello, Daniele; Cova, Agata; Squarcina, Paola; Frati, Paola; Di Giacomo, Anna Maria; Pilla, Lorenzo; Tazzari, Marcella; Camisaschi, Chiara; Arienti, Flavio; Castelli, Chiara; Rodolfo, Monica; Beretta, Valeria; Di Nicola, Massimo; Maio, Michel...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. Issue 4 (April 2017)

Authors:
Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Fo...
Journal:
Lancet oncology
Issue:
Volume 18:Issue 4(2017:Apr.)
Page Start:
435
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study. Issue 2 (17th November 2020)

Authors:
Rutkowski, Piotr; Indini, Alice; De Luca, Matilde; Merelli, Barbara; Mariuk-Jarema, Anna; Teterycz, Pawel; Rogala, Pawel; Lugowska, Iwona; Cybulska-Stopa, Bożena; Labianca, Alice; Di Guardo, Lorenza; Del Vecchio, Michele; Pigozzo, Jacopo; Randon, Giovanni; Corti, Francesca; Tondini, Carlo Alberto...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study. Issue 2 (17th November 2020)

Authors:
Rutkowski, Piotr; Indini, Alice; De Luca, Matilde; Merelli, Barbara; Mariuk-Jarema, Anna; Teterycz, Pawel; Rogala, Pawel; Lugowska, Iwona; Cybulska-Stopa, Bożena; Labianca, Alice; Di Guardo, Lorenza; Del Vecchio, Michele; Pigozzo, Jacopo; Randon, Giovanni; Corti, Francesca; Tondini, Carlo Alberto...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study. Issue 2 (17th November 2020)

Authors:
Rutkowski, Piotr; Indini, Alice; De Luca, Matilde; Merelli, Barbara; Mariuk-Jarema, Anna; Teterycz, Pawel; Rogala, Pawel; Lugowska, Iwona; Cybulska-Stopa, Bożena; Labianca, Alice; Di Guardo, Lorenza; Del Vecchio, Michele; Pigozzo, Jacopo; Randon, Giovanni; Corti, Francesca; Tondini, Carlo Alberto...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗